Gut Microbiota in Circadian Rhythm and Alzheimer’s Disease
DOI:
https://doi.org/10.61173/q639ws46Keywords:
gut microbiota, neuroninflmmation, Alzheimer’s Disease, circadian rhythmAbstract
Alzheimer’s disease (AD) causes a significant burden in society. However, the underlying pathology is still poorly understood. In addition to its classic suggested pathways, recent research also indicated that neuroinflammation may be a potential trigger of AD. Meanwhile, rhythm disruption may stimulate a systemic pro-inflammatory state. According to clinical studies, the altered gut microbiota composition has been reported in AD as well as sleep-deprived patients. These changes include the increased pro-inflammatory microbiota proportion, which has been found to induce neuroinflammation, neurodegeneration, β-amyloid (Aβ) production, and accumulation that may eventually lead to AD progression. Therefore, changes in gut microbiota have been suggested to be a potential linkage between rhythm disruption and AD.
References
[1] Kinney JW, Bemiller SM, Murtishaw AS, et al. Inflammation as a central mechanism in Alzheimer’s disease. Alzheimer’s & Dementia. Translational Research & Clinical Interventions. 2018, 4(1):575–590.
[2] Ma Q., Xing C., Long W., et al. Impact of microbiota on central nervous system and neurological diseases: The gut-brain axis. J. Neuroinflamm. 2019,16:1–14.
[3] Sun Y., Sommerville N.R., Liu J.Y.H., et al. Intragastrointestinal amyloid-β1-42 oligomers perturb enteric function and induce Alzheimer’s disease pathology. J. Physiol. 2020,598:4209–4223.
[4] Zhao Y, Jaber V, Lukiw WJ. Secretory products of the human GI tract microbiome and their potential impact on Alzheimer’s Dean&Francis disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus. Front Cell Infect Microbiol. 2017,7:318.
[5] Alexandrov P. Lipopolysaccharide-stimulated moleculargenetic communication between the human gut microbiome and the brain via NF-kB, miRNA-146a, and miRNA-155. Folia Neuropathol. 2019,57:211–219.
[6] Medeiros R., LaFerla F.M. Astrocytes: Conductors of the Alzheimer disease neuroinflammatory symphony. Exp. Neurol. 2013,239:133–138.
[7] Bagyinszky E., Giau V.V., Shim K., et al. Role of inflammatory molecules in the Alzheimer’s disease progression and diagnosis. J. Neurol. Sci. 2017,376:242–254.
[8] Decourt B., Lahiri D.K., Sabbagh M.N. Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease. Curr. Alzheimer Res. 2017,14:412–425.
[9] Krabbe G., Halle A., Matyash V., et al. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS ONE. 2013,8:e60921.
[10] Vogt N, Kerby RL, Dill‐McFarland KA, Harding S, et al. Gut microbiome alterations in Alzheimer’s disease. Scientific Reports 2017, 7(1).
[11] Deaver JA, Eum SY, Toborek M. Circadian disruption changes gut microbiome taxa and functional gene composition. Frontiers in Microbiology [Internet]. 2018 Apr 13;9.
[12] Hasan N, Yang H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ. 2019, 7:e7502.
[13] Grosicki GJ, Riemann BL, Flatt AA, Valentino T, Lustgarten MS. Self-reported sleep quality is associated with gut microbiome composition in young, healthy individuals: a pilot study. Sleep Medicine. 2020, 73:76–81.
[14] Smith RP, Easson CG, Lyle SM, Kapoor R, Donnelly CP, Davidson EJ, et al. Gut microbiome diversity is associated with sleep physiology in humans. PLOS ONE. 2019, 14(10):e0222394.
[15] Zhang S, Bai L, Goel N, Bailey A, et al. Human and rat gut microbiome composition is maintained following sleep restriction. Proceedings of the National Academy of Sciences of the United States of America. 2017, 114(8).
[16] Musiek ES, Bhimasani M, Zangrilli MA, et al. Circadian Rest-Activity pattern changes in aging and preclinical Alzheimer disease. JAMA Neurology. 2018, 75(5):582.
[17] Weissová K, Bartoš A, Sládek M, et al. Moderate changes in the circadian system of Alzheimer’s disease patients detected in their home environment. PLOS ONE. 2016, 11(1):e0146200.
[18] Liguori C, Romigi A, Nuccetelli M, et al. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. JAMA Neurology. 2014, 71(12):1498.
[19] Kang JE, Lim MM, Bateman RJ, et al. Amyloid-Β dynamics are regulated by Orexin and the Sleep-Wake cycle. Science. 2009, 326(5955):1005–1007.
[20] Wei T, Zhu H, Feng Y, et al.
The Impact of Gut Microbiota Disorders on the Blood–Brain Barrier
Infection and Drug Resistance. 2020, Volume 13:3351–3363.[21] Bedu-Ferrari C, Biscarrat P, Langella P, et al. Prebiotics and the human gut microbiota: From breakdown mechanisms to the impact on metabolic health. Nutrients. 2022, 14(10):2096.
[22] Kobayashi Y, Kuhara T, Oki M, et al. Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: a randomised, double-blind, placebo-controlled trial. Beneficial Microbes. 2019, 10(5):511– 520.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
